Anti-GAD

Three major antigens of Langerhans’ islets of pancreatic β-cells are glutamic acid decarboxylase (GAD), insulinoma-associated protein 2 (IA-2) and insulin. The determination of circulating autoantibodies against these structures are used for specific classification in diabetes mellitus  type I and LADA, as well as for diabetes prediction in first grade relatives of diabetic mellitus type I patients. Prevalence of Anti-GAD in DM type I patients is 70-90%.

Name IRMA Anti-GAD
Ref. IM3650/IM3651
Method IRMA
Type Homogenous phase
Tests 50/100
Max. Activity (kBq) 50/2x50
Sensitivity 0.2 U/mL
Incubation conditions 2 hrs/RT+1 hr/RT
Calibrator range 0;1-300 U/mL
Sample volume (μL) 20
Sample form serum
Analyte info                      
Instructions for Use         
MSDS